Cargando…
Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
Fatty acid synthase (FASN), a lipogenic multi-enzyme complex, is reported to be overexpressed in various types of of tumor tissues and serves an important role in tumor development and progression. However, the expression of FASN and its possible role in gastric cancer (GC) remains to be defined. In...
Autores principales: | DUAN, JIANGMAN, SUN, LI, HUANG, HONGXIANG, WU, ZHENZHEN, WANG, LIN, LIAO, WANGJUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805063/ https://www.ncbi.nlm.nih.gov/pubmed/26936091 http://dx.doi.org/10.3892/mmr.2016.4902 |
Ejemplares similares
-
Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
por: SU, YUQI, et al.
Publicado: (2015) -
High overexpression of fatty acid synthase is associated with poor survival in Chinese patients with gastric carcinoma
por: HOU, WENMIN, et al.
Publicado: (2012) -
Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
por: Huang, Chao, et al.
Publicado: (2020) -
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012) -
Overexpressing PLOD family genes predict poor prognosis in gastric cancer
por: Li, Shan-Shan, et al.
Publicado: (2020)